Takeda Avoids Most Claims In Actos Buyers' Antitrust Suit
Japanese pharmaceutical company Takeda scored a big win Tuesday when a New York federal judge agreed to dismiss all claims but one in a suit accusing the company of delaying generic...To view the full article, register now.
Already a subscriber? Click here to view full article